Clinical trial
Evaluation of the Impact of the QoLibri Digital Therapy on Primary Care Patients With Chronic Pain: a Randomized Controlled Clinical Trial.
NCT06841276 is registered in ClinicalTrials.gov with Novesia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Impact of the QoLibri Digital Therapy on Primary Care Patients With Chronic Pain: a Randomized Controlled Clinical Trial.
- Lead sponsor
- Novesia
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- February 28, 2025
- Completion date
- April 30, 2027
- Enrollment
- 410 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.